4.4 Article

Simultaneous quantification of seven hippocampal neurotransmitters in depression mice by LC-MS/MS

Journal

JOURNAL OF NEUROSCIENCE METHODS
Volume 229, Issue -, Pages 8-14

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneumeth.2014.04.004

Keywords

LC-MS/MS; Methylprednisolone; Neurotransmitter; Hippocampus

Funding

  1. National Natural Science Foundation of China [31270917]
  2. Key Project from Department of Education of China [20123107130002]
  3. Key Research Innovation Project [13ZZ099]
  4. Shanghai Eastern Scholar [2013-59]

Ask authors/readers for more resources

Background: There is no method available to simultaneously detect GABA, Glu, Epi, NE, DA, 5-HT and 5-HIAA in mouse hippocampus. New method: A rapid and sensitive LC-MS/MS method has been developed for simultaneously measuring seven neurotransmitters in mouse hippocampus. The analytes were detected in positive mode with multiple reaction monitoring (MRM) and the procedure was completed in less than 9 min. Results: This method exhibited excellent linearity for all of the analytes with regression coefficients higher than 0.99, and showed good intra- and inter-day precisions (RSD < 15%) with good accuracy (80-120%). Moreover, the method was successfully applied for the quantitative determination of neurotransmitters in a mouse depression model induced by successive methylprednisolone injections. The results indicated that this depression model was closely associated with the decreased level of Epi (p = 0.002) and elevated ratio of 5-HIAA/5-HT (p = 0.01), which has never been reported elsewhere. Comparison with existing method(s): Compared with previous methods, current approach is more convenient without any pre-column derivatization of the analytes but enhances detectability with incremental neurotransmitter profile and shortens detection time. Conclusions: This work represents the first accurate simultaneous determination of seven neurotransmitters in the mouse depression model induced by methylprednisolone. The reliable method will benefit the research of neurological diseases with the altered neurotransmitter profile in brain. (C) 2014 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available